Target intelligence / Profile preview

CD151 mRNA 3' untranslated region (CD151 3' UTR)

Target
CD151 3' UTR
Molecular classification
RNA regulatory element, Untranslated region
01

Overview

The CD151 mRNA 3' untranslated region (3' UTR) is a critical regulatory segment of the CD151 transcript that governs the stability and translation of the CD151 protein, a member of the tetraspanin superfamily [3, 6]. This region contains multiple cis-regulatory elements and binding sites for microRNAs (miRNAs), such as miR-22 and miR-637, which post-transcriptionally repress CD151 expression by inducing mRNA degradation or inhibiting translation [2, 5, 11]. CD151 itself is a key mediator of cellular processes including migration, invasion, and adhesion, primarily through its robust association with laminin-binding integrins like α3β1 and α6β4 [3, 12]. In various solid malignancies, such as breast, prostate, and lung cancers, CD151 is frequently overexpressed and correlates with advanced disease stages, metastasis, and resistance to anti-cancer therapies [6, 8, 10]. Consequently, the CD151 3' UTR is an attractive therapeutic target for RNA-based interventions, including antisense oligonucleotides (ASOs) and miRNA mimics, designed to silence CD151 and suppress its oncogenic activity [2, 7, 13]. Beyond oncology, the regulation of CD151 mRNA levels has been implicated in the therapeutic mechanisms of mood stabilizers like lithium and valproate in the treatment of bipolar disorder [1].

Other names
CD151 3' untranslated regionTSPAN24 mRNA 3' UTRPETA-3 mRNA 3' UTRSFA-1 mRNA 3' UTRGP-27 mRNA 3' UTR
02

Mechanism of action

miRNA-mediated translational repression and mRNA degradation; antisense oligonucleotide-mediated gene silencing through RNase H recruitment or steric hindrance of regulatory elements.

03

Biological functions

Post-transcriptional regulationmRNA stability regulationTranslational repressionCell migrationCell invasionCell-matrix adhesion
04

Disease associations

CancerMetastasisBipolar disorderNephropathyEpidermolysis bullosa
05

Safety considerations

Potential for nephropathy (glomerular disease) due to loss of CD151-integrin complexes in podocytesRisk of skin blistering (mechano-bullous disease) from impaired epithelial integrityOff-target effects associated with RNA-targeted therapeutics
06

Interacting drugs

miR-22 mimic

4 more in the full profile.

07

Biomarkers

CD151 mRNA expression levelsmiR-22 expression levelsmiR-637 expression levelsExosomal CD151

Beyond the preview

Go deeper on CD151 mRNA 3' untranslated region (CD151 3' UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD151 mRNA 3' untranslated region (CD151 3' UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call